Evidence-based toxicology for the 21st century: opportunities and challenges.

The Evidence-based Toxicology Collaboration (EBTC) was established recently to translate evidence-based approaches from medicine and health care to toxicology in an organized and sustained effort. The EBTC held a workshop on "Evidence-based Toxicology for the 21st Century: Opportunities and Challenges" in Research Triangle Park, North Carolina, USA on January 24-25, 2012. The presentations largely reflected two EBTC priorities: to apply evidence-based methods to assessing the performance of emerging pathway-based testing methods consistent with the 2007 National Research Council report on "Toxicity Testing in the 21st Century" as well as to adopt a governance structure and work processes to move that effort forward. The workshop served to clarify evidence-based approaches and to provide food for thought on substantive and administrative activities for the EBTC. Priority activities include conducting pilot studies to demonstrate the value of evidence-based approaches to toxicology, as well as conducting educational outreach on these approaches.

[1]  Krishna Prasad,et al.  Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium , 2010, Nature Biotechnology.

[2]  James A. Swenberg,et al.  Toxicology and Epidemiology: Improving the Science with a Framework for Combining Toxicological and Epidemiological Evidence to Establish Causal Inference , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  Philip Hewitt,et al.  Performance of novel kidney biomarkers in preclinical toxicity studies. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  Seema K. Schappelle,et al.  Enhancing the credibility of decisions based on scientific conclusions: transparency is imperative. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  Nancy G. Doerrer,et al.  Identification and Characterization of Adverse Effects in 21 st Century Toxicology , 2012 .

[6]  Patrice Sutton,et al.  An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. , 2011, Health affairs.

[7]  Eliseo Guallar,et al.  Arsenic Exposure and Hypertension: A Systematic Review , 2011, Environmental health perspectives.

[8]  A. Oxman,et al.  The origins, evolution, and future of The Cochrane Database of Systematic Reviews , 2009, International Journal of Technology Assessment in Health Care.

[9]  Sebastian Hoffmann,et al.  Diagnosis: toxic!--trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  Amy G. Aslamkhan,et al.  Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury , 2010, Nature Biotechnology.

[11]  G. Christiaens,et al.  Leading change , 2018, Leadership Transitions in Universities.

[12]  M. Longnecker,et al.  Evaluation of the Association between Arsenic and Diabetes: A National Toxicology Program Workshop Review , 2012, Environmental health perspectives.

[13]  T. Skopek,et al.  A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function , 2010, Nature Biotechnology.

[14]  T. Woodruff,et al.  Conrad and Becker’s “10 Criteria” Fall Short of Addressing Conflicts of Interest in Chemical Safety Studies , 2011, Environmental health perspectives.

[15]  Serafino Pantano,et al.  Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury , 2010, Nature Biotechnology.

[16]  E. Guallar,et al.  Lead Exposure and Cardiovascular Disease—A Systematic Review , 2006, Environmental health perspectives.

[17]  T Hartung,et al.  Toward an evidence-based toxicology , 2006, Human & experimental toxicology.

[18]  I. Zineh,et al.  Qualifying biomarkers for use in drug development: a US Food and Drug Administration overview. , 2011, Expert opinion on medical diagnostics.

[19]  T. Hartung.  Evidence-based toxicology - the toolbox of validation for the 21st century? , 2010, ALTEX.

[20]  S. Covey.  The seven habits of highly effective people : restoring the character ethic , 1989 .

[21]  Joanne Zurlo.  Evidence-based Toxicology Collaboration Kick-off Meeting , 2011 .

[22]  Jennifer Seed,et al.  Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.

[23]  A. Detsky,et al.  Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.

[24]  Thomas Hartung.  Food for thought... on evidence-based toxicology. , 2009, ALTEX.

[25]  Ellen Silbergeld,et al.  Evidence-based toxicology: strait is the gate, but the road is worth taking. , 2013, ALTEX.

[26]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[27]  Syril Pettit,et al.  Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  Melvin E. Andersen,et al.  Toxicity Testing in the 21st Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways , 2011, PloS one.

[29]  M. Hamburg,et al.  Advancing Regulatory Science , 2011, Science.

[30]  Kevork Hopayian,et al.  Essential Evidence-based Medicine , 2005, ACP Journal Club.

[31]  Michael S Victoroff,et al.  Evidence-based toxicology: a comprehensive framework for causation , 2005, Human & experimental toxicology.

[32]  Thomas Hartung,et al.  Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. , 2013, ALTEX.

[33]  R. Becker,et al.  Enhancing Credibility of Chemical Safety Studies: Emerging Consensus on Key Assessment Criteria , 2010, Environmental health perspectives.